Oxygenta Pharma - Quaterly Results

30 May 2025 Evaluate
The total revenue hovered 368.79% to Rs. 494.67 millions for the March 2025 quarter as against Rs. 105.52 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2025 is Rs. -21.52 millions as compared to Net Profit of Rs. 80.15 millions of corresponding quarter ended March 2024 Operating profit Margin for the quarter ended March 2025 further decreased to -16.34% as compared to -16.02% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 494.67 105.52 368.79 1092.99 396.42 175.72 1092.99 396.42 175.72
Other Income 0.49 0.13 276.92 13.09 0.42 3016.67 13.09 0.42 3016.67
PBIDT -16.34 -16.02 2.00 -86.84 -96.54 -10.05 -86.84 -96.54 -10.05
Interest 21.28 5.95 257.65 36.14 26.61 35.81 36.14 26.61 35.81
PBDT -40.32 -19.50 106.77 -125.68 -122.78 2.36 -125.68 -122.78 2.36
Depreciation -2.34 6.38 -136.68 17.82 15.94 11.79 17.82 15.94 11.79
PBT -37.98 -25.88 46.75 -143.50 -138.72 3.45 -143.50 -138.72 3.45
TAX -16.46 -106.03 -84.48 -40.53 -103.92 -61.00 -40.53 -103.92 -61.00
Deferred Tax -18.06 -106.03 -82.97 -42.13 -103.92 -59.46 -42.13 -103.92 -59.46
PAT -21.52 80.15 -126.85 -102.97 -34.80 195.89 -102.97 -34.80 195.89
Equity 369.84 334.84 10.45 369.84 334.84 10.45 369.84 334.84 10.45
PBIDTM(%) -3.30 -15.18 -78.24 -7.95 -24.35 -67.37 -7.95 -24.35 -67.37

Oxygenta Pharma Share Price

59.05 -0.50 (-0.84%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×